NASDAQ:TALK - Nasdaq - US87427V1035 - Common Stock - Currency: USD
TALKSPACE INC
NASDAQ:TALK (2/3/2025, 8:00:01 PM)
After market: 3.16 0 (0%)3.16
+0.06 (+1.94%)
The current stock price of TALK is 3.16 USD. In the past month the price increased by 0.96%. In the past year, price increased by 28.98%.
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:MDT),(NYSE:TDOC),(NASDAQ:TALK) EQNX::TICKER_END
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ: TALK), a leading online behavioral health company, is now available to approximately 9.5...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 10.7 | 81.35B | ||
CVS | CVS HEALTH CORP | 8.81 | 70.41B | ||
LH | LABCORP HOLDINGS INC | 17.19 | 20.73B | ||
DGX | QUEST DIAGNOSTICS INC | 18.21 | 18.13B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 177.66 | 14.54B | ||
DVA | DAVITA INC | 19.94 | 14.52B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.62 | 14.32B | ||
HIMS | HIMS & HERS HEALTH INC | 88.48 | 8.51B | ||
CHE | CHEMED CORP | 24.23 | 8.32B | ||
CRVL | CORVEL CORP | 24.62 | 5.96B | ||
GH | GUARDANT HEALTH INC | N/A | 5.88B | ||
OPCH | OPTION CARE HEALTH INC | 25.79 | 5.22B |
Talkspace, Inc. engages in the operation and development of a technology platform used in connecting patients to licensed mental health professionals through messaging, video, and audio. The company is headquartered in New York City, New York and currently employs 472 full-time employees. The company went IPO on 2020-06-09. Through its platform, the Company provides psychotherapy and psychiatry services to individuals, enterprises and health plans through both business-to-business (B2B) and business-to-customer (B2C) channels. In psychotherapy or talk therapy, members work with a licensed therapist or counsellor to treat specific mental health conditions, such as depression or anxiety, trauma and other human challenges, including by developing positive thinking and coping skills. In psychotherapy, the Company offers text, audio and video-based psychotherapy from licensed therapists. In psychiatry, members receive personalized, care from a prescriber who specializes in mental healthcare and prescription management. The firm offers its members a robust ecosystem for end-to-end behavioral healthcare.
TALKSPACE INC
622 Third Avenue
New York City NEW YORK US
CEO: Douglas G. Bergeron
Employees: 472
Company Website: https://www.talkspace.com/
Investor Relations: https://investors.talkspace.com/
Phone: 12122847206
The current stock price of TALK is 3.16 USD.
The exchange symbol of TALKSPACE INC is TALK and it is listed on the Nasdaq exchange.
TALK stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TALK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TALK.
TALK does not pay a dividend.
TALK will report earnings on 2025-02-25, after the market close.
TALK does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
The outstanding short interest for TALK is 3.45% of its float.
ChartMill assigns a technical rating of 6 / 10 to TALK. When comparing the yearly performance of all stocks, TALK is one of the better performing stocks in the market, outperforming 78.35% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to TALK. No worries on liquidiy or solvency for TALK as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months TALK reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 95.45% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.99% | ||
ROE | -1.17% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 82% to TALK. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 105.1% and a revenue growth 28.96% for TALK